Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2008
10/08/2008CN100423779C Medicinal composition comprising active components of 5-HT 3 receptor antagonist and H2 receptor antagonist and use thereof
10/08/2008CN100423778C Folic acid receptor targeted liposome medicine carrier, its preparation and application
10/08/2008CN100423776C Therapeutic agent
10/08/2008CN100423721C Thrombopoietin mimetics
10/08/2008CN100423715C New pharmaceutical composition
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof
10/07/2008US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
10/07/2008US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
10/07/2008US7432304 Providing cell which overexpresses a Bcl-2 family protein; gossypol compound; treating with cell with an effective amount of gossypol compound under conditions such that apoptosis in cell is modulated
10/07/2008US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432254 Method for treating glaucoma IC
10/07/2008US7432253 Phosphoepoxides, method for making same and uses
10/07/2008US7432247 Used to decrease the amount of inotrope needed after trauma or surgery
10/07/2008US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas
10/07/2008US7432067 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility
10/07/2008US7432049 Compositions and methods relating to osteoarthritis
10/07/2008CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
10/07/2008CA2419147C Fill liquid composition for ibuprofen capsule and capsule preparation
10/07/2008CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
10/07/2008CA2338646C Microparticles with adsorbent surfaces, methods of making same, and uses thereof
10/07/2008CA2330256C Treatment of inflammatory bowel disease
10/07/2008CA2280715C Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp.infection
10/07/2008CA2261263C Use of sex steroid function modulators to treat wounds and fibrotic disorders
10/07/2008CA2259984C Precise efficacy assay methods for active agents including chemotherapeutic agents
10/07/2008CA2237306C Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
10/02/2008WO2008118879A2 Antiviral compositions comprising 2 compounds
10/02/2008WO2008118744A1 Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
10/02/2008WO2008118552A1 Use of ranolazine for the treatment of cardiovascular diseases
10/02/2008WO2008118032A1 Compositions for treating intoxications comprising a phξnothiazine compound
10/02/2008WO2008117523A1 Antiviral agent
10/02/2008WO2008117389A1 Drug for treating retinal disorders, utilization of the same and therapeutic method using the same
10/02/2008WO2008116890A2 Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
10/02/2008WO2008116816A1 Combination of cb2 ligand and paracetamol
10/02/2008WO2008094484A3 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors
10/02/2008WO2008064321A3 Methods of treating chronic inflammatory diseases using a gm-csf antagonist
10/02/2008WO2008033655A3 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
10/02/2008WO2008026125A3 Anti cancer use of caffeic acid and derivatives
10/02/2008WO2007030602A3 Treatment of b cells with il-21 and b cell activators induces granzyme b production
10/02/2008US20080242722 composition comprising a nitric oxide donating compound (e.g. 5,6-bis(nitrooxy)hexyl acetate) and cyclooxygenase-2 selective inhibitor; antiinflammatory, analgesic agent; to reduce the gastrointestinal toxicity caused by aspirin and COX-inhibitor therapy
10/02/2008US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders
10/02/2008US20080242674 Medicine For Prevention or Treatment of Frequent Urination or Urinary Incontinence
10/02/2008US20080242614 Polypeptide containing valine or proline; therapy for infections
10/02/2008US20080242609 Composition for the therapy of diabetes mellitus and adiposity
10/02/2008US20080242591 Treating vascular malformation with nicotinic acetylcholine receptor (nAChR) antagonist; arthritis, cancer
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241861 Biological materials and methods useful in the diagnosis and treatment of diseases
10/02/2008US20080241857 Netrin receptors
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241257 Biodegradable Nanoparticles Incorporating Highly Hydrophilic Positively Charged Drugs
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241148 Treatment with anti-vegf antibodies
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241105 Pretreatment with oncolytic virus
10/02/2008US20080241101 Nutrient broth comprising serine protease inhibitors and cytokine for use propgation of skin basement membrane tissues; regenerative medicine; tissue repair
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008US20080241093 A potassium-binding polymer of a crosslinked ion exchange polymer having acid groups and an alpha/beta electronegative group in a bead form as an oral dosage; renal insufficiency; congestive heart failure; hyperkalemia; high preferential binding capaciity; stability; nonabsorbent; nontoxic
10/02/2008US20080241092 Administering a potassium-binding polymer of a crosslinked ion exchange polymer having acid groups and an alpha/beta electronegative group in a bead form as an oral dosage; renal insufficiency; congestive heart failure; hyperkalemia; high preferential binding capaciity; stability; nonabsorbent; nontoxic
10/02/2008US20080241078 Compositions and methods for treating hair loss using c16-c20 aromatic tetrahydro prostaglandins
10/02/2008US20080241067 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008DE202008006598U1 Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung Allergy vaccine formulation for mucosal administration
10/02/2008DE102007015035A1 Substituierte Dibenzoesäure-Derivate und ihre Verwendung Substituted dibenzoic acid derivatives and their use
10/02/2008CA2682015A1 Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
10/02/2008CA2681728A1 Combination of blys inhibition and/or april inhibition and immunosuppressants for treatment of autoimmune disease
10/02/2008CA2681567A1 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
10/02/2008CA2680834A1 Genetics variants associated with hiv disease restriction
10/02/2008CA2678272A1 Use of ranolazine for the treatment of cardiovascular diseases
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974750A1 Preventive or therapeutic agent and method for immune disease
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974738A2 Diagnostics and therapeutics for glaucoma
10/01/2008EP1974737A1 Composition for the treatment of diabetes mellitus and metabolic syndrome
10/01/2008EP1974736A1 A composition for the treatment of diabetes mellitus
10/01/2008EP1973569A2 Specific therapy using integrin ligands for treating cancer
10/01/2008EP1973552A2 Parenteral nutrition composition containing iron
10/01/2008EP1713477B1 Combination of voriconazole and an antifungal cyp2c19 inhibitor
10/01/2008EP1608377B1 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
10/01/2008EP1587522B1 Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
10/01/2008EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008EP1251862B1 Ophthalmic compositions for treating ocular hypertension
10/01/2008EP1091745B1 Treatment of hyperproliferative disorders
10/01/2008CN101277740A Antituberculous composition comprising oxazole compounds
10/01/2008CN101277719A Medical agent containing insulin resistance improving agent
10/01/2008CN101277612A Composition and method for use in cartilage affecting conditions
10/01/2008CN101274960A Genes associated with leishmania parasite virulence
10/01/2008CN101274098A Treatment with anti-VEGF antibodies
10/01/2008CN101273987A Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
10/01/2008CN101273981A Preparation and method for treating diabetes
10/01/2008CN101273970A Microemulsion type preparation of glucocorticoid medicine for nasal cavity
10/01/2008CN101273967A Anticancer sustained-release injection containing neovascularization inhibitor
1 ... 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 ... 1151